| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 1.63e-09 | 21 | 16 | 4 | GO:0061676 | |
| GeneOntologyMolecularFunction | disaccharide binding | 1.47e-08 | 7 | 16 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 3.54e-08 | 9 | 16 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 4.77e-07 | 20 | 16 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | syntaxin binding | 5.88e-07 | 87 | 16 | 4 | GO:0019905 | |
| GeneOntologyMolecularFunction | SNARE binding | 3.52e-06 | 136 | 16 | 4 | GO:0000149 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 3.10e-05 | 78 | 16 | 3 | GO:0043539 | |
| GeneOntologyMolecularFunction | protein kinase binding | 3.77e-05 | 873 | 16 | 6 | GO:0019901 | |
| GeneOntologyMolecularFunction | kinase binding | 6.77e-05 | 969 | 16 | 6 | GO:0019900 | |
| GeneOntologyMolecularFunction | microtubule binding | 8.73e-05 | 308 | 16 | 4 | GO:0008017 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 2.12e-04 | 149 | 16 | 3 | GO:0030295 | |
| GeneOntologyMolecularFunction | kinase activator activity | 2.57e-04 | 159 | 16 | 3 | GO:0019209 | |
| GeneOntologyMolecularFunction | tubulin binding | 3.09e-04 | 428 | 16 | 4 | GO:0015631 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 1.07e-03 | 259 | 16 | 3 | GO:0019887 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 1.31e-03 | 1099 | 16 | 5 | GO:0008092 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 1.71e-03 | 305 | 16 | 3 | GO:0019207 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.79e-03 | 310 | 16 | 3 | GO:0030246 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 1.44e-02 | 656 | 16 | 3 | GO:0008047 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 1.45e-02 | 1233 | 16 | 4 | GO:0140677 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 7.34e-10 | 18 | 16 | 4 | GO:0090166 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 9.29e-10 | 19 | 16 | 4 | GO:0060050 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 1.53e-09 | 4 | 16 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 2.12e-09 | 23 | 16 | 4 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 2.54e-09 | 24 | 16 | 4 | GO:0060049 | |
| GeneOntologyBiologicalProcess | Golgi localization | 4.19e-09 | 27 | 16 | 4 | GO:0051645 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 4.89e-09 | 28 | 16 | 4 | GO:0090306 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 4.89e-09 | 28 | 16 | 4 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 4.89e-09 | 28 | 16 | 4 | GO:0048313 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 6.14e-09 | 614 | 16 | 8 | GO:0010720 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 1.10e-08 | 34 | 16 | 4 | GO:0008356 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 1.40e-08 | 36 | 16 | 4 | GO:0010560 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 1.57e-08 | 37 | 16 | 4 | GO:0000212 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 1.80e-08 | 112 | 16 | 5 | GO:0010507 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 2.14e-08 | 8 | 16 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 2.17e-08 | 40 | 16 | 4 | GO:1903020 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 4.60e-08 | 48 | 16 | 4 | GO:0032733 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 9.30e-08 | 57 | 16 | 4 | GO:0007020 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 1.73e-07 | 15 | 16 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 1.73e-07 | 15 | 16 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein biosynthetic process | 2.02e-07 | 69 | 16 | 4 | GO:0010559 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 2.59e-07 | 17 | 16 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 2.67e-07 | 192 | 16 | 5 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-10 production | 2.69e-07 | 74 | 16 | 4 | GO:0032653 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 3.10e-07 | 18 | 16 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | interleukin-10 production | 3.16e-07 | 77 | 16 | 4 | GO:0032613 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 3.16e-07 | 77 | 16 | 4 | GO:0051289 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 3.68e-07 | 19 | 16 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 3.68e-07 | 19 | 16 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein metabolic process | 3.69e-07 | 80 | 16 | 4 | GO:1903018 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 4.33e-07 | 20 | 16 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 5.05e-07 | 21 | 16 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 5.40e-07 | 1095 | 16 | 8 | GO:0060284 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 6.47e-07 | 92 | 16 | 4 | GO:0090307 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 7.39e-07 | 1141 | 16 | 8 | GO:0045597 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 9.85e-07 | 26 | 16 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | positive regulation of mononuclear cell migration | 1.06e-06 | 104 | 16 | 4 | GO:0071677 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 1.14e-06 | 106 | 16 | 4 | GO:0032091 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 1.24e-06 | 28 | 16 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 1.48e-06 | 113 | 16 | 4 | GO:0051262 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.53e-06 | 114 | 16 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 1.54e-06 | 30 | 16 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | microtubule polymerization | 1.70e-06 | 117 | 16 | 4 | GO:0046785 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 1.70e-06 | 31 | 16 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 1.70e-06 | 31 | 16 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 1.87e-06 | 32 | 16 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 2.01e-06 | 122 | 16 | 4 | GO:0045132 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 2.06e-06 | 33 | 16 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 2.93e-06 | 37 | 16 | 3 | GO:0033081 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 3.18e-06 | 38 | 16 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 3.72e-06 | 40 | 16 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 3.72e-06 | 40 | 16 | 3 | GO:2000515 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte chemotaxis | 3.78e-06 | 143 | 16 | 4 | GO:0002688 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 4.01e-06 | 41 | 16 | 3 | GO:2000406 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 4.01e-06 | 41 | 16 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 4.32e-06 | 42 | 16 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 4.32e-06 | 42 | 16 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 4.64e-06 | 43 | 16 | 3 | GO:0060391 | |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 4.69e-06 | 151 | 16 | 4 | GO:0007052 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | 4.71e-06 | 1458 | 16 | 8 | GO:0051247 | |
| GeneOntologyBiologicalProcess | spindle assembly | 4.94e-06 | 153 | 16 | 4 | GO:0051225 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell activation | 4.94e-06 | 153 | 16 | 4 | GO:0035710 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 5.20e-06 | 155 | 16 | 4 | GO:0032649 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 5.33e-06 | 45 | 16 | 3 | GO:0045920 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 5.41e-06 | 354 | 16 | 5 | GO:0050769 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 5.70e-06 | 46 | 16 | 3 | GO:0051353 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 5.76e-06 | 159 | 16 | 4 | GO:0006888 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell migration | 5.90e-06 | 160 | 16 | 4 | GO:0071675 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 6.08e-06 | 47 | 16 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 6.08e-06 | 47 | 16 | 3 | GO:2000316 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 6.51e-06 | 164 | 16 | 4 | GO:0007098 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 6.90e-06 | 49 | 16 | 3 | GO:2000403 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 6.90e-06 | 49 | 16 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 7.16e-06 | 168 | 16 | 4 | GO:0031109 | |
| GeneOntologyBiologicalProcess | Golgi organization | 7.16e-06 | 168 | 16 | 4 | GO:0007030 | |
| GeneOntologyBiologicalProcess | type II interferon production | 7.33e-06 | 169 | 16 | 4 | GO:0032609 | |
| GeneOntologyBiologicalProcess | negative regulation of binding | 7.50e-06 | 170 | 16 | 4 | GO:0051100 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon production | 7.80e-06 | 51 | 16 | 3 | GO:0032689 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 8.27e-06 | 52 | 16 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell activation | 8.27e-06 | 52 | 16 | 3 | GO:0046636 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 8.48e-06 | 1090 | 16 | 7 | GO:0022603 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 8.76e-06 | 53 | 16 | 3 | GO:0048247 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 8.76e-06 | 53 | 16 | 3 | GO:0046640 | |
| GeneOntologyBiologicalProcess | organelle localization | 9.17e-06 | 703 | 16 | 6 | GO:0051640 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte migration | 9.20e-06 | 179 | 16 | 4 | GO:0002687 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 9.20e-06 | 179 | 16 | 4 | GO:0031023 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 9.27e-06 | 54 | 16 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | regulation of autophagy | 9.80e-06 | 400 | 16 | 5 | GO:0010506 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 1.04e-05 | 56 | 16 | 3 | GO:2000404 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in mitosis | 1.09e-05 | 187 | 16 | 4 | GO:1902850 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 1.21e-05 | 418 | 16 | 5 | GO:0009895 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 1.21e-05 | 418 | 16 | 5 | GO:0051962 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 1.21e-05 | 59 | 16 | 3 | GO:0046633 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 1.34e-05 | 61 | 16 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 1.48e-05 | 63 | 16 | 3 | GO:0043300 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.48e-05 | 63 | 16 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | organelle disassembly | 1.54e-05 | 204 | 16 | 4 | GO:1903008 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 1.55e-05 | 64 | 16 | 3 | GO:0072538 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 1.79e-05 | 212 | 16 | 4 | GO:0000070 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.94e-05 | 802 | 16 | 6 | GO:0048812 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 9.24e-09 | 33 | 16 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | cis-Golgi network | 4.46e-07 | 85 | 16 | 4 | GO:0005801 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 6.69e-07 | 94 | 16 | 4 | GO:0032580 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.26e-06 | 110 | 16 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | Golgi cisterna | 2.85e-06 | 135 | 16 | 4 | GO:0031985 | |
| GeneOntologyCellularComponent | coated vesicle | 5.51e-06 | 360 | 16 | 5 | GO:0030135 | |
| GeneOntologyCellularComponent | Golgi stack | 7.29e-06 | 171 | 16 | 4 | GO:0005795 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.38e-05 | 201 | 16 | 4 | GO:0072686 | |
| GeneOntologyCellularComponent | spindle pole | 1.49e-05 | 205 | 16 | 4 | GO:0000922 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 4.26e-05 | 934 | 16 | 6 | GO:0048471 | |
| GeneOntologyCellularComponent | Golgi membrane | 1.53e-04 | 721 | 16 | 5 | GO:0000139 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 2.96e-04 | 443 | 16 | 4 | GO:0098791 | |
| GeneOntologyCellularComponent | spindle | 3.73e-04 | 471 | 16 | 4 | GO:0005819 | |
| GeneOntologyCellularComponent | microtubule | 5.96e-04 | 533 | 16 | 4 | GO:0005874 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.76e-03 | 1228 | 16 | 5 | GO:0036477 | |
| GeneOntologyCellularComponent | neuronal cell body | 3.13e-03 | 835 | 16 | 4 | GO:0043025 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 4.09e-03 | 899 | 16 | 4 | GO:0099513 | |
| GeneOntologyCellularComponent | cell body | 4.59e-03 | 929 | 16 | 4 | GO:0044297 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.10e-03 | 530 | 16 | 3 | GO:0062023 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.06e-02 | 1179 | 16 | 4 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.09e-02 | 1187 | 16 | 4 | GO:0099081 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.27e-02 | 656 | 16 | 3 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.28e-02 | 658 | 16 | 3 | GO:0030312 | |
| MousePheno | increased alveolar macrophage number | 6.26e-10 | 14 | 14 | 4 | MP:0014228 | |
| MousePheno | abnormal alveolar macrophage number | 8.54e-10 | 15 | 14 | 4 | MP:0014227 | |
| MousePheno | abnormal Golgi vesicle transport | 4.56e-09 | 22 | 14 | 4 | MP:0030949 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 6.61e-09 | 24 | 14 | 4 | MP:0031355 | |
| MousePheno | abnormal alveolar macrophage morphology | 1.09e-08 | 27 | 14 | 4 | MP:0008245 | |
| MousePheno | absent sperm mitochondrial sheath | 1.27e-08 | 28 | 14 | 4 | MP:0009833 | |
| MousePheno | absent acrosome | 2.23e-08 | 32 | 14 | 4 | MP:0008839 | |
| MousePheno | abnormal Golgi apparatus morphology | 2.53e-08 | 33 | 14 | 4 | MP:0011743 | |
| MousePheno | abnormal actin cytoskeleton morphology | 2.87e-08 | 34 | 14 | 4 | MP:0020849 | |
| MousePheno | abnormal lymph node B cell domain morphology | 8.35e-08 | 44 | 14 | 4 | MP:0002344 | |
| MousePheno | abnormal microtubule cytoskeleton morphology | 1.00e-07 | 46 | 14 | 4 | MP:0020850 | |
| MousePheno | abnormal lymph node cortex morphology | 1.41e-07 | 50 | 14 | 4 | MP:0002343 | |
| MousePheno | pulmonary fibrosis | 1.53e-07 | 51 | 14 | 4 | MP:0006050 | |
| MousePheno | abnormal surfactant physiology | 2.59e-07 | 58 | 14 | 4 | MP:0004782 | |
| MousePheno | immotile sperm | 2.78e-07 | 59 | 14 | 4 | MP:0020869 | |
| MousePheno | abnormal type II pneumocyte morphology | 4.65e-07 | 67 | 14 | 4 | MP:0002275 | |
| MousePheno | decreased Purkinje cell number | 4.65e-07 | 67 | 14 | 4 | MP:0000880 | |
| MousePheno | abnormal Purkinje cell number | 5.24e-07 | 69 | 14 | 4 | MP:0000878 | |
| MousePheno | enhanced humoral immune response | 5.39e-07 | 17 | 14 | 3 | MP:0020155 | |
| MousePheno | abnormal myeloid leukocyte morphology | GOLGA6C GOLGA6D LGALS9C DACH2 LGALS9B GOLGA6B GOLGA6A BCL3 LGALS9 | 6.24e-07 | 1292 | 14 | 9 | MP:0008250 |
| MousePheno | abnormal sperm nucleus morphology | 6.96e-07 | 74 | 14 | 4 | MP:0009232 | |
| MousePheno | globozoospermia | 6.96e-07 | 74 | 14 | 4 | MP:0002686 | |
| MousePheno | increased B cell proliferation | 7.34e-07 | 75 | 14 | 4 | MP:0005154 | |
| MousePheno | abnormal cell cytoskeleton morphology | 7.34e-07 | 75 | 14 | 4 | MP:0020378 | |
| MousePheno | increased T-helper 1 cell number | 7.68e-07 | 19 | 14 | 3 | MP:0008086 | |
| MousePheno | abnormal pulmonary alveolus epithelial cell morphology | 8.17e-07 | 77 | 14 | 4 | MP:0002273 | |
| MousePheno | liver fibrosis | 8.17e-07 | 77 | 14 | 4 | MP:0003333 | |
| MousePheno | abnormal pulmonary alveolus epithelium morphology | 9.53e-07 | 80 | 14 | 4 | MP:0010898 | |
| MousePheno | abnormal Peyer's patch morphology | 1.11e-06 | 83 | 14 | 4 | MP:0000696 | |
| MousePheno | abnormal gut-associated lymphoid tissue morphology | 1.22e-06 | 85 | 14 | 4 | MP:0002378 | |
| MousePheno | abnormal lymph node germinal center morphology | 1.40e-06 | 23 | 14 | 3 | MP:0008522 | |
| MousePheno | increased spleen germinal center size | 1.40e-06 | 23 | 14 | 3 | MP:0008483 | |
| MousePheno | abnormal pulmonary alveolar parenchyma morphology | 1.53e-06 | 90 | 14 | 4 | MP:0010901 | |
| MousePheno | abnormal T-helper 1 cell number | 1.60e-06 | 24 | 14 | 3 | MP:0008085 | |
| MousePheno | abnormal acrosome assembly | 1.67e-06 | 92 | 14 | 4 | MP:0031354 | |
| MousePheno | abnormal phagocyte morphology | 1.74e-06 | 1033 | 14 | 8 | MP:0008251 | |
| MousePheno | abnormal lymph node secondary follicle morphology | 1.82e-06 | 25 | 14 | 3 | MP:0002346 | |
| MousePheno | abnormal sperm mitochondrial sheath morphology | 1.90e-06 | 95 | 14 | 4 | MP:0009832 | |
| MousePheno | decreased sperm progressive motility | 2.34e-06 | 100 | 14 | 4 | MP:0020451 | |
| MousePheno | abnormal sperm progressive motility | 2.43e-06 | 101 | 14 | 4 | MP:0020450 | |
| MousePheno | abnormal spleen germinal center morphology | 3.06e-06 | 107 | 14 | 4 | MP:0002359 | |
| MousePheno | abnormal spleen secondary B follicle morphology | 3.30e-06 | 109 | 14 | 4 | MP:0008472 | |
| MousePheno | lymph node hyperplasia | 4.29e-06 | 33 | 14 | 3 | MP:0008102 | |
| MousePheno | abnormal lung epithelium morphology | 4.52e-06 | 118 | 14 | 4 | MP:0006382 | |
| MousePheno | thymus hyperplasia | 4.70e-06 | 34 | 14 | 3 | MP:0000708 | |
| MousePheno | abnormal macrophage cell number | 5.19e-06 | 278 | 14 | 5 | MP:0020202 | |
| MousePheno | increased susceptibility to induced arthritis | 5.60e-06 | 36 | 14 | 3 | MP:0003724 | |
| MousePheno | abnormal sperm midpiece morphology | 9.98e-06 | 144 | 14 | 4 | MP:0009831 | |
| MousePheno | abnormal spleen B cell follicle morphology | 9.98e-06 | 144 | 14 | 4 | MP:0008470 | |
| MousePheno | abnormal B cell proliferation | 1.24e-05 | 152 | 14 | 4 | MP:0005153 | |
| MousePheno | abnormal T-helper 1 cell morphology | 1.35e-05 | 48 | 14 | 3 | MP:0002433 | |
| MousePheno | abnormal vesicle-mediated transport | 1.37e-05 | 156 | 14 | 4 | MP:0008546 | |
| MousePheno | abnormal acrosome morphology | 1.48e-05 | 159 | 14 | 4 | MP:0008898 | |
| MousePheno | abnormal B cell activation | 1.75e-05 | 166 | 14 | 4 | MP:0008217 | |
| MousePheno | abnormal hepatocyte morphology | 1.75e-05 | 166 | 14 | 4 | MP:0000607 | |
| MousePheno | decreased testis weight | 2.08e-05 | 370 | 14 | 5 | MP:0004852 | |
| MousePheno | increased T-helper cell number | 2.15e-05 | 56 | 14 | 3 | MP:0013763 | |
| MousePheno | abnormal testis weight | 2.71e-05 | 391 | 14 | 5 | MP:0004850 | |
| MousePheno | decreased regulatory T cell number | 3.21e-05 | 64 | 14 | 3 | MP:0004974 | |
| MousePheno | abnormal Purkinje cell morphology | 3.93e-05 | 204 | 14 | 4 | MP:0000877 | |
| MousePheno | slow postnatal weight gain | 4.01e-05 | 205 | 14 | 4 | MP:0008489 | |
| MousePheno | abnormal spermatid morphology | 5.00e-05 | 217 | 14 | 4 | MP:0006380 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 5.28e-05 | 220 | 14 | 4 | MP:0000875 | |
| MousePheno | abnormal macrophage morphology | 6.10e-05 | 463 | 14 | 5 | MP:0002446 | |
| MousePheno | abnormal liver lobule morphology | 6.17e-05 | 229 | 14 | 4 | MP:0008987 | |
| MousePheno | abnormal respiratory epithelium morphology | 6.83e-05 | 235 | 14 | 4 | MP:0010942 | |
| MousePheno | abnormal spermiogenesis | 7.05e-05 | 237 | 14 | 4 | MP:0001932 | |
| MousePheno | spleen hyperplasia | 7.52e-05 | 85 | 14 | 3 | MP:0000693 | |
| MousePheno | decreased body length | 7.53e-05 | 484 | 14 | 5 | MP:0001258 | |
| MousePheno | increased CD4-positive, alpha-beta T cell number | 7.53e-05 | 241 | 14 | 4 | MP:0008074 | |
| MousePheno | abnormal liver parenchyma morphology | 7.77e-05 | 243 | 14 | 4 | MP:0008986 | |
| MousePheno | abnormal pulmonary alveolus morphology | 9.37e-05 | 255 | 14 | 4 | MP:0002270 | |
| MousePheno | abnormal sperm head morphology | 1.03e-04 | 261 | 14 | 4 | MP:0009230 | |
| MousePheno | abnormal cerebellar layer morphology | 1.06e-04 | 263 | 14 | 4 | MP:0009956 | |
| MousePheno | ataxia | 1.10e-04 | 266 | 14 | 4 | MP:0001393 | |
| MousePheno | abnormal CD4-positive helper T cell morphology | 1.22e-04 | 100 | 14 | 3 | MP:0010183 | |
| MousePheno | abnormal body length | 1.38e-04 | 550 | 14 | 5 | MP:0001256 | |
| MousePheno | abnormal spleen white pulp morphology | 1.40e-04 | 283 | 14 | 4 | MP:0002357 | |
| MousePheno | abnormal pulmonary acinus morphology | 1.42e-04 | 284 | 14 | 4 | MP:0010911 | |
| MousePheno | abnormal lymph node size | 1.51e-04 | 561 | 14 | 5 | MP:0000701 | |
| MousePheno | autoimmune arthritis | 1.53e-04 | 108 | 14 | 3 | MP:0002993 | |
| MousePheno | abnormal sperm flagellum morphology | 1.65e-04 | 295 | 14 | 4 | MP:0008892 | |
| MousePheno | abnormal pulmonary alveolar system morphology | 1.67e-04 | 296 | 14 | 4 | MP:0010899 | |
| MousePheno | abnormal cerebellar cortex morphology | 1.76e-04 | 300 | 14 | 4 | MP:0004097 | |
| MousePheno | abnormal T-helper cell number | 1.80e-04 | 114 | 14 | 3 | MP:0013761 | |
| MousePheno | abnormal regulatory T cell number | 1.85e-04 | 115 | 14 | 3 | MP:0004972 | |
| MousePheno | abnormal regulatory T cell morphology | 1.94e-04 | 117 | 14 | 3 | MP:0004941 | |
| MousePheno | increased alpha-beta T cell number | 2.02e-04 | 311 | 14 | 4 | MP:0012764 | |
| MousePheno | joint inflammation | 2.71e-04 | 131 | 14 | 3 | MP:0002933 | |
| MousePheno | asthenozoospermia | 3.60e-04 | 362 | 14 | 4 | MP:0002675 | |
| MousePheno | abnormal joint physiology | 3.66e-04 | 145 | 14 | 3 | MP:0031169 | |
| MousePheno | abnormal lymph node morphology | 3.80e-04 | 683 | 14 | 5 | MP:0002339 | |
| MousePheno | abnormal motile cilium morphology | 3.92e-04 | 370 | 14 | 4 | MP:0013206 | |
| MousePheno | abnormal T-helper cell morphology | 3.96e-04 | 149 | 14 | 3 | MP:0013760 | |
| MousePheno | decreased neuron number | 4.16e-04 | 376 | 14 | 4 | MP:0008948 | |
| MousePheno | abnormal mononuclear phagocyte morphology | 4.40e-04 | 705 | 14 | 5 | MP:0008248 | |
| MousePheno | increased susceptibility to autoimmune disorder | 4.45e-04 | 155 | 14 | 3 | MP:0005350 | |
| MousePheno | oligozoospermia | 4.51e-04 | 384 | 14 | 4 | MP:0002687 | |
| MousePheno | abnormal cerebellum morphology | 4.74e-04 | 389 | 14 | 4 | MP:0000849 | |
| MousePheno | abnormal CD4-positive, alpha-beta T cell number | 4.83e-04 | 391 | 14 | 4 | MP:0008073 | |
| Domain | Golgin_A | 1.09e-09 | 18 | 16 | 4 | IPR024858 | |
| Domain | GOLGA2L5 | 1.09e-09 | 18 | 16 | 4 | PF15070 | |
| Domain | GALECTIN | 2.33e-07 | 15 | 16 | 3 | PS51304 | |
| Domain | GLECT | 2.33e-07 | 15 | 16 | 3 | SM00276 | |
| Domain | Gal-bind_lectin | 2.33e-07 | 15 | 16 | 3 | SM00908 | |
| Domain | Galectin_CRD | 2.33e-07 | 15 | 16 | 3 | IPR001079 | |
| Domain | Gal-bind_lectin | 2.33e-07 | 15 | 16 | 3 | PF00337 | |
| Domain | - | 6.80e-05 | 95 | 16 | 3 | 2.60.120.200 | |
| Domain | ConA-like_dom | 7.96e-04 | 219 | 16 | 3 | IPR013320 | |
| Domain | Ubiquitin-rel_dom | 1.06e-02 | 184 | 16 | 2 | IPR029071 | |
| Domain | RRM_1 | 1.34e-02 | 208 | 16 | 2 | PF00076 | |
| Domain | RRM | 1.45e-02 | 217 | 16 | 2 | SM00360 | |
| Domain | RRM_dom | 1.58e-02 | 227 | 16 | 2 | IPR000504 | |
| Domain | RRM | 1.62e-02 | 230 | 16 | 2 | PS50102 | |
| Domain | - | 1.81e-02 | 244 | 16 | 2 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 2.01e-02 | 258 | 16 | 2 | IPR012677 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 1.76e-09 | 23 | 11 | 4 | MM14620 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 1.24e-07 | 64 | 11 | 4 | MM15601 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 3.57e-07 | 83 | 11 | 4 | MM14819 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.11e-06 | 110 | 11 | 4 | MM15350 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.28e-06 | 114 | 11 | 4 | MM15361 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 3.53e-06 | 649 | 11 | 6 | MM15690 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 6.02e-06 | 168 | 11 | 4 | MM14785 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 1.25e-05 | 202 | 11 | 4 | MM15650 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 5.38e-05 | 293 | 11 | 4 | MM15120 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 7.25e-05 | 645 | 11 | 5 | MM15232 | |
| Pathway | REACTOME_M_PHASE | 1.58e-04 | 387 | 11 | 4 | MM15364 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.57e-04 | 439 | 11 | 4 | MM15595 | |
| Pathway | WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER | 7.46e-04 | 53 | 11 | 2 | M39688 | |
| Pathway | REACTOME_CELL_CYCLE | 8.60e-04 | 603 | 11 | 4 | MM14635 | |
| Pubmed | Development of the post-natal growth plate requires intraflagellar transport proteins. | 1.59e-13 | 20 | 16 | 5 | 17359961 | |
| Pubmed | 4.36e-13 | 24 | 16 | 5 | 24161848 | ||
| Pubmed | Lis1 mediates planar polarity of auditory hair cells through regulation of microtubule organization. | 2.85e-12 | 34 | 16 | 5 | 23533177 | |
| Pubmed | 3.32e-12 | 35 | 16 | 5 | 39366759 | ||
| Pubmed | 7.65e-12 | 41 | 16 | 5 | 30022023 | ||
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 2.13e-11 | 13 | 16 | 4 | 29128360 | |
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 2.13e-11 | 13 | 16 | 4 | 28055014 | |
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 2.13e-11 | 13 | 16 | 4 | 28028212 | |
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 2.13e-11 | 13 | 16 | 4 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 2.13e-11 | 13 | 16 | 4 | 32873390 | |
| Pubmed | 2.13e-11 | 13 | 16 | 4 | 21552007 | ||
| Pubmed | 2.98e-11 | 14 | 16 | 4 | 37831422 | ||
| Pubmed | 2.98e-11 | 14 | 16 | 4 | 30630895 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 2.98e-11 | 14 | 16 | 4 | 27226319 | |
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 2.98e-11 | 14 | 16 | 4 | 33543287 | |
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 4.06e-11 | 15 | 16 | 4 | 23185636 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 4.06e-11 | 15 | 16 | 4 | 17046993 | |
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 4.06e-11 | 15 | 16 | 4 | 26165940 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 4.06e-11 | 15 | 16 | 4 | 17189423 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 4.06e-11 | 15 | 16 | 4 | 17204322 | |
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 4.06e-11 | 15 | 16 | 4 | 28509431 | |
| Pubmed | 4.06e-11 | 15 | 16 | 4 | 26083584 | ||
| Pubmed | 4.06e-11 | 15 | 16 | 4 | 16413118 | ||
| Pubmed | 4.06e-11 | 15 | 16 | 4 | 37635409 | ||
| Pubmed | 5.42e-11 | 16 | 16 | 4 | 16336229 | ||
| Pubmed | 5.42e-11 | 16 | 16 | 4 | 18166528 | ||
| Pubmed | 5.42e-11 | 16 | 16 | 4 | 11784862 | ||
| Pubmed | 5.42e-11 | 16 | 16 | 4 | 16399995 | ||
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 5.42e-11 | 16 | 16 | 4 | 21640725 | |
| Pubmed | 7.08e-11 | 17 | 16 | 4 | 28717168 | ||
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 7.08e-11 | 17 | 16 | 4 | 14718562 | |
| Pubmed | 7.08e-11 | 17 | 16 | 4 | 20004763 | ||
| Pubmed | 7.08e-11 | 17 | 16 | 4 | 27655914 | ||
| Pubmed | 7.08e-11 | 17 | 16 | 4 | 14728599 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 16990264 | ||
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 7.99e-11 | 3 | 16 | 3 | 29458010 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 18005988 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 23585851 | ||
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 7.99e-11 | 3 | 16 | 3 | 31969388 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 23836896 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 18282810 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 24477688 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 19776007 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 7.99e-11 | 3 | 16 | 3 | 29433546 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 26582205 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 7.99e-11 | 3 | 16 | 3 | 35241678 | |
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 7.99e-11 | 3 | 16 | 3 | 7890611 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 37105392 | ||
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 7.99e-11 | 3 | 16 | 3 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 7.99e-11 | 3 | 16 | 3 | 28990062 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 32380082 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 24083426 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 23667648 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 9153289 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 33316546 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 37279535 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 18974023 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 18579572 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 7.99e-11 | 3 | 16 | 3 | 25931247 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 9038233 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 22627368 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 28877989 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 33153471 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 19800850 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 22052881 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 17560833 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 23144904 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 38987795 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 7.99e-11 | 3 | 16 | 3 | 29651447 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 36479526 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 28704475 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 21146220 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 23242525 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 35643073 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 7.99e-11 | 3 | 16 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 7.99e-11 | 3 | 16 | 3 | 33923930 | |
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 7.99e-11 | 3 | 16 | 3 | 23408620 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 7.99e-11 | 3 | 16 | 3 | 25898318 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 31937306 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 21426359 | ||
| Pubmed | 9.10e-11 | 18 | 16 | 4 | 21147753 | ||
| Pubmed | 9.10e-11 | 18 | 16 | 4 | 15800058 | ||
| Pubmed | 9.10e-11 | 18 | 16 | 4 | 24227724 | ||
| Pubmed | 9.10e-11 | 18 | 16 | 4 | 20943658 | ||
| Pubmed | Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1. | 9.10e-11 | 18 | 16 | 4 | 20230794 | |
| Pubmed | 9.10e-11 | 18 | 16 | 4 | 22718342 | ||
| Pubmed | Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons. | 9.10e-11 | 18 | 16 | 4 | 24367100 | |
| Pubmed | 9.10e-11 | 18 | 16 | 4 | 25208654 | ||
| Pubmed | Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells. | 1.15e-10 | 19 | 16 | 4 | 14622145 | |
| Pubmed | 1.15e-10 | 19 | 16 | 4 | 23444373 | ||
| Pubmed | CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development. | 1.15e-10 | 19 | 16 | 4 | 35705037 | |
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 1.15e-10 | 19 | 16 | 4 | 17664336 | |
| Pubmed | 1.15e-10 | 19 | 16 | 4 | 12646573 | ||
| Pubmed | Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration. | 1.15e-10 | 19 | 16 | 4 | 38048369 | |
| Pubmed | Stage-dependent function of Wnt5a during male external genitalia development. | 1.15e-10 | 19 | 16 | 4 | 34255394 | |
| Pubmed | 1.15e-10 | 19 | 16 | 4 | 17724343 | ||
| Pubmed | 1.15e-10 | 19 | 16 | 4 | 22841714 | ||
| Pubmed | Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2. | 1.15e-10 | 19 | 16 | 4 | 17003038 | |
| Pubmed | 1.15e-10 | 19 | 16 | 4 | 15452145 | ||
| Pubmed | Cell influx and contractile actomyosin force drive mammary bud growth and invagination. | 1.15e-10 | 19 | 16 | 4 | 34042944 | |
| Interaction | CLRN3 interactions | 1.89e-10 | 13 | 16 | 4 | int:CLRN3 | |
| Interaction | RRAGB interactions | 9.94e-06 | 54 | 16 | 3 | int:RRAGB | |
| Interaction | ABCC4 interactions | 1.11e-05 | 56 | 16 | 3 | int:ABCC4 | |
| Interaction | RRAGC interactions | 2.68e-05 | 75 | 16 | 3 | int:RRAGC | |
| Interaction | CD47 interactions | 3.13e-05 | 79 | 16 | 3 | int:CD47 | |
| Interaction | SLC12A6 interactions | 1.20e-04 | 124 | 16 | 3 | int:SLC12A6 | |
| Interaction | ANO6 interactions | 1.29e-04 | 127 | 16 | 3 | int:ANO6 | |
| Interaction | SLC12A4 interactions | 1.35e-04 | 129 | 16 | 3 | int:SLC12A4 | |
| Interaction | SLC12A7 interactions | 1.45e-04 | 132 | 16 | 3 | int:SLC12A7 | |
| Interaction | DAG1 interactions | 1.51e-04 | 134 | 16 | 3 | int:DAG1 | |
| Interaction | SLC4A2 interactions | 1.54e-04 | 135 | 16 | 3 | int:SLC4A2 | |
| Interaction | CD58 interactions | 1.61e-04 | 24 | 16 | 2 | int:CD58 | |
| Interaction | DBN1 interactions | 2.70e-04 | 417 | 16 | 4 | int:DBN1 | |
| Interaction | LUM interactions | 2.89e-04 | 32 | 16 | 2 | int:LUM | |
| Interaction | LGALS9C interactions | 3.46e-04 | 35 | 16 | 2 | int:LGALS9C | |
| Interaction | SLC38A9 interactions | 3.46e-04 | 35 | 16 | 2 | int:SLC38A9 | |
| Interaction | SLC4A7 interactions | 3.84e-04 | 184 | 16 | 3 | int:SLC4A7 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q24 | 8.43e-08 | 122 | 16 | 4 | chr15q24 | |
| Cytoband | 15q24.2 | 5.61e-05 | 32 | 16 | 2 | 15q24.2 | |
| Cytoband | 15q24.1 | 6.35e-05 | 34 | 16 | 2 | 15q24.1 | |
| Cytoband | 17p11.2 | 1.39e-03 | 159 | 16 | 2 | 17p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p11 | 2.24e-03 | 203 | 16 | 2 | chr17p11 | |
| GeneFamily | Galectins | 5.52e-08 | 15 | 10 | 3 | 629 | |
| GeneFamily | RNA binding motif containing | 5.84e-03 | 213 | 10 | 2 | 725 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN | 2.30e-06 | 160 | 16 | 4 | MM974 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_DN | 1.66e-05 | 83 | 16 | 3 | MM596 | |
| Coexpression | BURTON_ADIPOGENESIS_9 | 2.05e-05 | 89 | 16 | 3 | MM1026 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 2.34e-05 | 93 | 16 | 3 | MM1137 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN | 2.37e-05 | 289 | 16 | 4 | MM1238 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | 2.82e-05 | 1088 | 16 | 6 | MM3699 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 2.91e-05 | 100 | 16 | 3 | MM514 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 3.62e-05 | 322 | 16 | 4 | MM3786 | |
| Coexpression | MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP | 4.42e-05 | 115 | 16 | 3 | MM599 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 5.24e-05 | 720 | 16 | 5 | MM3700 | |
| Coexpression | MARKEY_RB1_CHRONIC_LOF_DN | 6.37e-05 | 130 | 16 | 3 | MM975 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 8.28e-05 | 142 | 16 | 3 | MM840 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 8.99e-05 | 146 | 16 | 3 | MM973 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.14e-04 | 158 | 16 | 3 | MM17063 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.41e-04 | 170 | 16 | 3 | M5880 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 | 1.51e-04 | 174 | 16 | 3 | MM836 | |
| Coexpression | UEDA_PERIFERAL_CLOCK | 1.59e-04 | 177 | 16 | 3 | MM1145 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_ASTROCYTE_AGEING | 1.62e-04 | 474 | 16 | 4 | MM3685 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 1.90e-04 | 188 | 16 | 3 | MM983 | |
| Coexpression | GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN | 2.15e-04 | 196 | 16 | 3 | M4404 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN | 2.28e-04 | 200 | 16 | 3 | M5132 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN | 2.28e-04 | 200 | 16 | 3 | M9079 | |
| Coexpression | GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN | 2.28e-04 | 200 | 16 | 3 | M9081 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN | 2.28e-04 | 200 | 16 | 3 | M5603 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN | 2.86e-04 | 550 | 16 | 4 | MM1004 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 2.89e-04 | 217 | 16 | 3 | MM1156 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN | 3.09e-04 | 222 | 16 | 3 | MM1132 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 3.84e-04 | 239 | 16 | 3 | MM1274 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | 4.22e-04 | 1124 | 16 | 5 | MM1070 | |
| Coexpression | TABULA_MURIS_SENIS_SKIN_EPIDERMAL_CELL_AGEING | 4.44e-04 | 618 | 16 | 4 | MM3829 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | 5.28e-04 | 647 | 16 | 4 | MM981 | |
| Coexpression | QI_PLASMACYTOMA_UP | 5.54e-04 | 271 | 16 | 3 | MM1045 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | 6.20e-04 | 675 | 16 | 4 | MM1073 | |
| Coexpression | TABULA_MURIS_SENIS_THYMUS_THYMOCYTE_AGEING | 7.14e-04 | 701 | 16 | 4 | MM3849 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_STEM_CELL_AGEING | 7.94e-04 | 721 | 16 | 4 | MM3800 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_MYELOID_MICROGLIAL_CELL_AGEING | 1.22e-03 | 356 | 16 | 3 | MM3684 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 180 | 16 | 3 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.51e-05 | 182 | 16 | 3 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | Mild-NK|World / Disease group and Cell class | 3.68e-05 | 185 | 16 | 3 | 0565b7c464e1a09e596f5a0b363d2dc9b55c3c50 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.51e-05 | 198 | 16 | 3 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.51e-05 | 198 | 16 | 3 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | Biopsy_Other_PF|World / Sample group, Lineage and Cell type | 4.64e-05 | 200 | 16 | 3 | fc41a9fb855ae5a5c73a769f18ec7a14f42f18ec | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-03 | 149 | 16 | 2 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-03 | 153 | 16 | 2 | 0b3b199678d4a70b0590393568c69454bece5c14 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-03 | 157 | 16 | 2 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-03 | 157 | 16 | 2 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.42e-03 | 158 | 16 | 2 | 41aff0a09a7087a67d0ac91028e4895df729289b | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-03 | 162 | 16 | 2 | 59c0dcb5b51c1803660aeec51b60deceeeaeea66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.50e-03 | 162 | 16 | 2 | 9b1c07f0af657095379380c39d763cab0ad73e74 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-03 | 167 | 16 | 2 | 721a932024d55de7212dc6ec9e4d7f463c2bcda2 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 167 | 16 | 2 | 73fdf4b81a45ec686d2929eaf641b434f70b7898 | |
| ToppCell | facs-Tongue-nan-24m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 167 | 16 | 2 | c4157fb31b44fe7c44be4215dda8ae2d37cf49a8 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 1.61e-03 | 168 | 16 | 2 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-03 | 170 | 16 | 2 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | facs|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-03 | 171 | 16 | 2 | 5bcb96ed7fc15548f2dc9cf47482f890640cb39c | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-03 | 171 | 16 | 2 | 317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736 | |
| ToppCell | facs|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-03 | 171 | 16 | 2 | bb71e816dde44fda6af0ad98d979be9f8740fda6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.68e-03 | 172 | 16 | 2 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.68e-03 | 172 | 16 | 2 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.68e-03 | 172 | 16 | 2 | fe3d0d8cb5f613ac2cfff450599698f1533a354f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.68e-03 | 172 | 16 | 2 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-03 | 173 | 16 | 2 | bba8265a58f8f5659dc7b9da2fe27b15033fce34 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.70e-03 | 173 | 16 | 2 | 8407c9156ab35900858de5273586129d7e283c5b | |
| ToppCell | COVID-19_Moderate-NK_CD56bright|COVID-19_Moderate / disease group, cell group and cell class | 1.70e-03 | 173 | 16 | 2 | a07dcb1e555caaa2235aec219334fcbf2d07f10c | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.72e-03 | 174 | 16 | 2 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-03 | 175 | 16 | 2 | 8727252bcbc70bfa2ff72e7421df9cfe6fd4eed7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-03 | 175 | 16 | 2 | c083abe368e5c0dc2b0f27f375c9271a2d7ff64f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-03 | 175 | 16 | 2 | d427c1eaea805046b1e4944d374adc7095f710a1 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.76e-03 | 176 | 16 | 2 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.78e-03 | 177 | 16 | 2 | 0f2616a81f8fbede77c860b2126e3fa826672da3 | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.80e-03 | 178 | 16 | 2 | 0139b42494c1186390b12106dea7957e2b6717c2 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 1.82e-03 | 179 | 16 | 2 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-03 | 179 | 16 | 2 | e717c0079b788a3703c0a450922bd5a2bdc322a0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-03 | 180 | 16 | 2 | 1c1b25f1d22518db5469707131510daae84716a3 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-03 | 180 | 16 | 2 | 9c47852c0a723e2f5cd6898afff4c31a0da06905 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-03 | 180 | 16 | 2 | 499d5fe71e0dc20cffdf85e3b3f14eb4e83e3a3d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.84e-03 | 180 | 16 | 2 | 535a890bde0d978b461c2d4c571529b585c76b21 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-03 | 180 | 16 | 2 | 2405aa5699a8d8cf4c6b3dca07510e774728ac50 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-03 | 180 | 16 | 2 | 2bc3fd2e4c249bf236340c5f0483747faa5c04ec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-03 | 181 | 16 | 2 | 1b4eb044825ede6361928442524b1988c8ef58b3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-03 | 181 | 16 | 2 | 8d7ebbedc373d55e29da02ac2728b4f4118038f2 | |
| ToppCell | HSPCs-Ery/Mk_prog.|HSPCs / Lineage and Cell class | 1.90e-03 | 183 | 16 | 2 | 59cfb02143b6b54dfca7560562e064948f0340ca | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.92e-03 | 184 | 16 | 2 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.92e-03 | 184 | 16 | 2 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.92e-03 | 184 | 16 | 2 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class | 1.92e-03 | 184 | 16 | 2 | ad6e910eaebe841a68a5f2f329d43dafc5db158a | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.94e-03 | 185 | 16 | 2 | 3b2da51aec057b462749ae39afb8f253afcf38d5 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.94e-03 | 185 | 16 | 2 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.96e-03 | 186 | 16 | 2 | 5ad37549592eab23f166196ebf0cb9c8ddf26082 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.96e-03 | 186 | 16 | 2 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.96e-03 | 186 | 16 | 2 | c984e5729958237b101df96d1c89a236faacded6 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-03 | 187 | 16 | 2 | 63834420db930df91b62494c9d7aaa9a25bca530 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-03 | 187 | 16 | 2 | 6cf7be5401b81a4eeb30840fb3733d61a24af539 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.98e-03 | 187 | 16 | 2 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-NK-Intermediate_NK|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.01e-03 | 188 | 16 | 2 | a8170e4ce6406af9f5ad5317e6e26efa7bc66411 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.03e-03 | 189 | 16 | 2 | 3e148accffc6ab249fb0dff7f3bf5a7fff9da773 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-03 | 189 | 16 | 2 | bed43041e6f8ba19787150a6aaa492f2656135d9 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.05e-03 | 190 | 16 | 2 | 251d50a77e5118a9ad19ea01a7c7c862230ed63c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-03 | 191 | 16 | 2 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-03 | 191 | 16 | 2 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-03 | 192 | 16 | 2 | aedddccacf60e884af044cefba6c64ca10ac97d2 | |
| ToppCell | BAL-Mild|BAL / Compartment, Disease Groups and Clusters | 2.09e-03 | 192 | 16 | 2 | 1a6cbf014d3f7a3fb6f53adab078c4742e7137de | |
| ToppCell | MS-NK|MS / Condition, Cell_class and T cell subcluster | 2.09e-03 | 192 | 16 | 2 | f44f5dd30db169fdd16c9d706d17ad44907a17af | |
| ToppCell | MS-NK-|MS / Condition, Cell_class and T cell subcluster | 2.09e-03 | 192 | 16 | 2 | f97f5f8226f5c65ca93072ef35d753231bee2490 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-03 | 192 | 16 | 2 | 0b954a4e5857dac45d97c491af9b27cb2d1bd339 | |
| ToppCell | control-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.09e-03 | 192 | 16 | 2 | cec6ab5793953072e6b0fee370551224947dd877 | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_Natural_Killer_Cell|Distal / Age, Tissue, Lineage and Cell class | 2.09e-03 | 192 | 16 | 2 | dd47d47d0a7219771b275c4cf5f2b768424216c8 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.09e-03 | 192 | 16 | 2 | 63e815664b228575886396387d2738cd73855759 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-03 | 192 | 16 | 2 | 389d5e6d0689371bfe1d0b06e92e0e6e5573567b | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.09e-03 | 192 | 16 | 2 | 095151a4f878944835945f698aa0e3b540ffc8c3 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.09e-03 | 192 | 16 | 2 | e48bbcb97c113f323ad4db96bd10d593b9206923 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-03 | 193 | 16 | 2 | 46f94a1062b098205e8ce3ed380c0202a4d97678 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type | 2.11e-03 | 193 | 16 | 2 | f110f86db305e41639087f5b1a2dff103c07adf0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-03 | 193 | 16 | 2 | 54604c2c5dce2ff6f3ec7ca82b595b09b8cdafe8 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-03 | 193 | 16 | 2 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.13e-03 | 194 | 16 | 2 | 5a859885c0f9b8554b0d203e371c70928ad4418f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-03 | 194 | 16 | 2 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.13e-03 | 194 | 16 | 2 | dc4aeee379423827e8d291cffe4dbdf2ff6d0bbe | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-03 | 194 | 16 | 2 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-03 | 194 | 16 | 2 | 1a188e52f2f0b6eca3e8d4a4671d9beab0fbbb88 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-03 | 194 | 16 | 2 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 2.13e-03 | 194 | 16 | 2 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.13e-03 | 194 | 16 | 2 | aee60da2e7aed161cdd4abbfad6864665aaa8f5c | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 2.13e-03 | 194 | 16 | 2 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.13e-03 | 194 | 16 | 2 | 7d35ac70ba966eb1fee4197f7de6d6116326a442 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.13e-03 | 194 | 16 | 2 | afa8d29924719af3bc5f48f22cf66d5e8f9e3e37 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-NK-Cycling_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.13e-03 | 194 | 16 | 2 | af08047e5728ee8198d2686af6a774f2acfa58ba | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 2.15e-03 | 195 | 16 | 2 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-NK-CD16+_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.15e-03 | 195 | 16 | 2 | eadc2f8dd16d2b76c59b85f72905bd4b1545b560 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-03 | 195 | 16 | 2 | 9ecae6c26a0d0607d101ccf1c38f0b23c5a256a8 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease, Lineage and Cell Type | 2.15e-03 | 195 | 16 | 2 | 35b2fe0588877d30cbd5d3ae259fcfd959907429 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 2.15e-03 | 195 | 16 | 2 | c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 2.15e-03 | 195 | 16 | 2 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-03 | 195 | 16 | 2 | 3365768101454060b9ea96ef6b426c76c150bc8f | |
| ToppCell | T/NK_cells-CD56dim_NK_cell|World / Lineage and Cell class | 2.15e-03 | 195 | 16 | 2 | 6124e87cb9061bf8918377fb4a79084079ddfc16 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-03 | 195 | 16 | 2 | 98b02beafe1d418442e41f85cbf0c7b194fe5957 | |
| Drug | diglycerol phosphate | 3.01e-06 | 5 | 13 | 2 | CID000439964 | |
| Drug | Grgd Peptide | 1.35e-05 | 10 | 13 | 2 | CID000126679 | |
| Drug | Rges Peptide | 7.56e-05 | 23 | 13 | 2 | CID000121927 | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.05e-04 | 167 | 13 | 3 | 966_UP | |
| Drug | AC1L1DD6 | 1.29e-04 | 179 | 13 | 3 | CID000002299 | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; HL60; HG-U133A | 1.47e-04 | 187 | 13 | 3 | 2017_UP | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 1.56e-04 | 191 | 13 | 3 | 1225_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 1.69e-04 | 196 | 13 | 3 | 1658_UP | |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; PC3; HG-U133A | 1.69e-04 | 196 | 13 | 3 | 1892_DN | |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.69e-04 | 196 | 13 | 3 | 4629_DN | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; HL60; HT_HG-U133A | 1.71e-04 | 197 | 13 | 3 | 1333_DN | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 1uM; PC3; HT_HG-U133A | 1.74e-04 | 198 | 13 | 3 | 4562_UP | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.76e-04 | 199 | 13 | 3 | 7126_DN | |
| Drug | Trapidil [15421-84-8]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 1.79e-04 | 200 | 13 | 3 | 7475_DN | |
| Drug | glycerophosphorylethanolamine | 1.88e-04 | 36 | 13 | 2 | CID000123874 | |
| Disease | hearing loss | 2.26e-04 | 67 | 10 | 2 | EFO_0004238 | |
| Disease | Alzheimer disease | 4.86e-04 | 485 | 10 | 3 | MONDO_0004975 | |
| Disease | pelvic organ prolapse | 9.26e-04 | 136 | 10 | 2 | EFO_0004710 | |
| Disease | apolipoprotein B measurement | 1.20e-03 | 663 | 10 | 3 | EFO_0004615 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLDLPFMMMPHPLLP | 311 | Q96NX9 | |
| FMMMPHPLLPVSLPP | 316 | Q96NX9 | |
| PYNPMMVVMMPPPPP | 676 | O14641 | |
| MWPQPYLPPHPMMLE | 1 | Q9NYA3 | |
| AGYPQPMPPTHPMPM | 51 | Q969X1 | |
| PMMYPHPAYPMPFIT | 216 | Q6DKI2 | |
| PMMYPHPAYPMPFIT | 216 | Q3B8N2 | |
| PAIPPMMYPHPAYPM | 211 | O00182 | |
| MWPQPYLPPHPMMLE | 1 | A6NDN3 | |
| PTMMPPPPRHMYSPV | 126 | Q9Y2H6 | |
| MWPQPYLPPHPMMLE | 1 | A6NDK9 | |
| MWPQPYLPPHPMMLE | 1 | P0CG33 | |
| LPTPLYPMMCPMEHP | 106 | P20749 | |
| QRFPLMPPRPMPPHM | 871 | O95104 | |
| MPPRPMPPHMMHRGP | 876 | O95104 | |
| LPMPPNCPPTLYSLM | 641 | Q05397 | |
| QPSFPLLPDMPPMHM | 2166 | Q68DE3 | |
| PRIMHHMPGQPPYMP | 151 | P09012 |